| Prod. No. | Product Name | Size |
| Effective: 21-Aug-06 | | |
| CAY-10006556-M005 | Latanoprost-d4 | 5 mg |
| CAY-10006579-M050 | Methyl .gamma.-Linolenate | 50 mg |
| CAY-10006579-M100 | Methyl .gamma.-Linolenate | 100 mg |
| CAY-10006579-M250 | Methyl .gamma.-Linolenate | 250 mg |
| CAY-10006579-G001 | Methyl .gamma.-Linolenate | 1 g |
| CAY-10006580-M010 | Dihomo-.gamma.-Linolenic Acid methyl ester | 10 mg |
| CAY-10006580-M050 | Dihomo-.gamma.-Linolenic Acid methyl ester | 50 mg |
| CAY-10006580-M100 | Dihomo-.gamma.-Linolenic Acid methyl ester | 100 mg |
| CAY-10006580-M500 | Dihomo-.gamma.-Linolenic Acid methyl ester | 500 mg |
| CAY-10006588-1 | Goat Anti-Rabbit IgG FITC | 1 ea |
| CAY-10006590-1 | CB1 Receptor (C-Term) Polyclonal Antibody | 1 ea |
| CAY-10006591-1 | CB1 Receptor (C-Term) Blocking Peptide | 1 ea |
| CAY-10006593-C050 | Prostaglandin D Synthase (hematopoietic-type) (human) (recombinant) | 50 ug |
| CAY-10006593-C100 | Prostaglandin D Synthase (hematopoietic-type) (human) (recombinant) | 100 ug |
| CAY-10006593-C250 | Prostaglandin D Synthase (hematopoietic-type) (human) (recombinant) | 250 ug |
| CAY-10006594-M010 | Losartan (potassium salt) | 10 mg |
| CAY-10006594-M050 | Losartan (potassium salt) | 50 mg |
| CAY-10006594-M100 | Losartan (potassium salt) | 100 mg |
| CAY-10006594-M500 | Losartan (potassium salt) | 500 mg |
| CAY-10006595-KI01 | Prostaglandin D Synthase Inhibitor Screening Assay Kit | 96 wells |
| CAY-10006606-C500 | Retreversine | 500 ug |
| CAY-10006606-M001 | Retreversine | 1 mg |
| CAY-10006606-M005 | Retreversine | 5 mg |
| CAY-10006606-M010 | Retreversine | 10 mg |
| CAY-10006607-M025 | Arachidonic Acid (sodium salt) | 25 mg |
| CAY-10006607-M050 | Arachidonic Acid (sodium salt) | 50 mg |
| CAY-10006607-M100 | Arachidonic Acid (sodium salt) | 100 mg |
| CAY-10006607-M500 | Arachidonic Acid (sodium salt) | 500 mg |
| CAY-10006610-M001 | Thromboxane B1 | 1 mg |
| CAY-10006610-M005 | Thromboxane B1 | 5 mg |
| CAY-10006610-M010 | Thromboxane B1 | 10 mg |
| CAY-10006610-M050 | Thromboxane B1 | 50 mg |
| CAY-10006616-1 | S1P1 Blocking Peptide | 1 ea |
| CAY-10006617-1 | Goat Anti-Mouse (IgG+IgM) - FITC | 1 ea |
| CAY-10006618-1 | 5-OxoETE Receptor Blocking Peptide | 1 ea |
| CAY-10006620-1 | Serine Palmitoyltransferase Blocking Peptide | 1 ea |
| CAY-10006626-G025 | Lauric Acid | 25 g |
| CAY-10006626-G050 | Lauric Acid | 50 g |
| CAY-10006626-G100 | Lauric Acid | 100 g |
| CAY-10006626-G250 | Lauric Acid | 250 g |
| CAY-10006627-G010 | Palmitic Acid | 10 g |
| CAY-10006627-G025 | Palmitic Acid | 25 g |
| CAY-10006627-G050 | Palmitic Acid | 50 g |
| CAY-10006627-G100 | Palmitic Acid | 100 g |
| CAY-10006647-KI01 | Enterolactone EIA Kit (Solid Plate) | 96 wells |
| CAY-10006647-KI04 | Enterolactone EIA Kit (Solid Plate) | 480 wells |
| CAY-10006654-C010 | iPF2.alpha.-VI-d11 | 10 ug |
| CAY-10006654-C025 | iPF2.alpha.-VI-d11 | 25 ug |
| CAY-10006654-C050 | iPF2.alpha.-VI-d11 | 50 ug |
| CAY-10006654-C100 | iPF2.alpha.-VI-d11 | 100 ug |
| CAY-10006661-G001 | Ketoprofen | 1 g |
| CAY-10006661-G005 | Ketoprofen | 5 g |
| CAY-10006661-G010 | Ketoprofen | 10 g |
| CAY-10006661-G025 | Ketoprofen | 25 g |
| CAY-10006692-M001 | 15-epi-Cloprostenol | 1 mg |
| CAY-10006692-M005 | 15-epi-Cloprostenol | 5 mg |
| CAY-10006692-M010 | 15-epi-Cloprostenol | 10 mg |
| CAY-10006692-M050 | 15-epi-Cloprostenol | 50 mg |
| CAY-10006695-M005 | HEPC | 5 mg |
| CAY-10006695-M010 | HEPC | 10 mg |
| CAY-10006695-M025 | HEPC | 25 mg |
| CAY-10006695-M050 | HEPC | 50 mg |
| CAY-10006697-C050 | Prostaglandin D2-biotinimide | 50 ug |
| CAY-10006697-C100 | Prostaglandin D2-biotinimide | 100 ug |
| CAY-10006697-C500 | Prostaglandin D2-biotinimide | 500 ug |
| CAY-10006697-M001 | Prostaglandin D2-biotinimide | 1 mg |
| CAY-10006726-M001 | PD 98059 | 1 mg |
| CAY-10006726-M005 | PD 98059 | 5 mg |
| CAY-10006726-M010 | PD 98059 | 10 mg |
| CAY-10006726-M050 | PD 98059 | 50 mg |
| CAY-10006727-M001 | PD 169316 | 1 mg |
| CAY-10006727-M005 | PD 169316 | 5 mg |
| CAY-10006727-M010 | PD 169316 | 10 mg |
| CAY-10006727-M025 | PD 169316 | 25 mg |
| CAY-10006731-M005 | VDM11 | 5 mg |
| CAY-10006731-M010 | VDM11 | 10 mg |
| CAY-10006731-M025 | VDM11 | 25 mg |
| CAY-10006731-M050 | VDM11 | 50 mg |
| CAY-10006733-M001 | Lipocrine | 1 mg |
| CAY-10006733-M005 | Lipocrine | 5 mg |
| CAY-10006733-M010 | Lipocrine | 10 mg |
| CAY-10006733-M050 | Lipocrine | 50 mg |
| CAY-10006734-M001 | CAY10470 | 1 mg |
| CAY-10006734-M005 | CAY10470 | 5 mg |
| CAY-10006734-M010 | CAY10470 | 10 mg |
| CAY-10006734-M050 | CAY10470 | 50 mg |
| CAY-10006735-M001 | CAY10471 | 1 mg |
| CAY-10006735-M005 | CAY10471 | 5 mg |
| CAY-10006735-M010 | CAY10471 | 10 mg |
| CAY-10006735-M050 | CAY10471 | 50 mg |
| CAY-10006778-1 | Nitrotyrosine (Peptide) Polyclonal Antibody | 1 ea |
| CAY-10006782-M005 | Oleic Acid-2,6-diisopropyl Anilide | 5 mg |
| CAY-10006782-M010 | Oleic Acid-2,6-diisopropyl Anilide | 10 mg |
| CAY-10006782-M050 | Oleic Acid-2,6-diisopropyl Anilide | 50 mg |
| CAY-10006782-M100 | Oleic Acid-2,6-diisopropyl Anilide | 100 mg |
| CAY-10006787-C100 | Prostaglandin D Synthase (lipocalin-type) (murine) (recombinant) | 100 ug |
| CAY-10006787-C250 | Prostaglandin D Synthase (lipocalin-type) (murine) (recombinant) | 250 ug |
| CAY-10006787-C500 | Prostaglandin D Synthase (lipocalin-type) (murine) (recombinant) | 500 ug |
| CAY-10006788-C100 | Prostaglandin D Synthase (lipocalin-type) (human) (recombinant) | 100 ug |
| CAY-10006788-C250 | Prostaglandin D Synthase (lipocalin-type) (human) (recombinant) | 250 ug |
| CAY-10006788-C500 | Prostaglandin D Synthase (lipocalin-type) (human) (recombinant) | 500 ug |
| CAY-10006789-1 | ChREBP Polyclonal Antibody | 1 ea |
| CAY-10006791-KI01 | Cortisol Express EIA Kit | 96 wells |
| CAY-10006791-KI04 | Cortisol Express EIA Kit | 480 wells |
| CAY-10006794-C100 | (+)-Xestospongin A | 100 ug |
| CAY-10006794-C250 | (+)-Xestospongin A | 250 ug |
| CAY-10006797-C100 | Araguspongin B | 100 ug |
| CAY-10006797-C250 | Araguspongin B | 250 ug |
| CAY-10006800-M001 | (R)-Bromoenol lactone | 1 mg |
| CAY-10006800-M005 | (R)-Bromoenol lactone | 5 mg |
| CAY-10006800-M010 | (R)-Bromoenol lactone | 10 mg |
| CAY-10006800-M050 | (R)-Bromoenol lactone | 50 mg |
| CAY-10006801-M001 | (S)-Bromoenol lactone | 1 mg |
| CAY-10006801-M005 | (S)-Bromoenol lactone | 5 mg |
| CAY-10006801-M010 | (S)-Bromoenol lactone | 10 mg |
| CAY-10006801-M050 | (S)-Bromoenol lactone | 50 mg |
| CAY-10006803-M001 | O-1602 | 1 mg |
| CAY-10006803-M005 | O-1602 | 5 mg |
| CAY-10006803-M010 | O-1602 | 10 mg |
| CAY-10006803-M050 | O-1602 | 50 mg |
| CAY-10006804-M001 | O-1821 | 1 mg |
| CAY-10006804-M005 | O-1821 | 5 mg |
| CAY-10006804-M010 | O-1821 | 10 mg |
| CAY-10006804-M050 | O-1821 | 50 mg |
| CAY-10006809-M005 | Heptanoyl Thio-PC | 5 mg |
| CAY-10006809-M010 | Heptanoyl Thio-PC | 10 mg |
| CAY-10006809-M025 | Heptanoyl Thio-PC | 25 mg |
| CAY-10006809-M050 | Heptanoyl Thio-PC | 50 mg |
| CAY-10006830-1 | 6-keto Prostaglandin F1alpha Quant-PAK | 1 vial |
| CAY-10006831-1 | 11-dehydro Thromboxane B2 Quant-PAK | 1 vial |
| CAY-10006832-1 | Thromboxane B2 Quant-PAK | 1 vial |
| CAY-10006833-1 | Omega-3 Arachidonic Acid Quant-PAK | 1 vial |
| CAY-10006834-1 | Linoleic Acid Quant-PAK | 1 vial |
| CAY-10006835-1 | Arachidonic Acid Quant-PAK | 1 vial |
| CAY-10006840-1 | Prostaglandin A2 Quant-PAK | 1 vial |
| CAY-10006841-1 | Prostaglandin B2 Quant-PAK | 1 vial |
| CAY-10006842-1 | Prostaglandin D1 Quant-PAK | 1 vial |
| CAY-10006843-1 | Prostaglandin D2 Quant-PAK | 1 vial |
| CAY-10006844-1 | Prostaglandin E1 Quant-PAK | 1 vial |
| CAY-10006845-1 | 13,14-Dihydro Prostaglandin E1 Quant-PAK | 1 vial |
| CAY-10006846-1 | Prostaglandin E2 Quant-PAK | 1 vial |
| CAY-10006848-1 | Prostaglandin F2alpha Quant-PAK | 1 vial |
| CAY-10006850-1 | 15-Deoxy-delta12,14-Prostaglandin J2 Quant-PAK | 1 vial |
| CAY-10006855-KI01 | PPARgamma Transcription Factor Assay Kit | 96 wells |
| CAY-10006856-M001 | Stearidonic Acid ethyl esther | 1 mg |
| CAY-10006856-M005 | Stearidonic Acid ethyl esther | 5 mg |
| CAY-10006856-M010 | Stearidonic Acid ethyl esther | 10 mg |
| CAY-10006856-M050 | Stearidonic Acid ethyl esther | 50 mg |
| CAY-10006859-M001 | N-HBG | 1 mg |
| CAY-10006859-M005 | N-HBG | 5 mg |
| CAY-10006859-M010 | N-HBG | 10 mg |
| CAY-10006859-M025 | N-HBG | 25 mg |
| CAY-10006860-M001 | N-HFG | 1 mg |
| CAY-10006860-M005 | N-HFG | 5 mg |
| CAY-10006860-M010 | N-HFG | 10 mg |
| CAY-10006860-M025 | N-HFG | 25 mg |
| CAY-10006864-M005 | cis-7-Hexadecenoic Acid methyl ester | 5 mg |
| CAY-10006864-M010 | cis-7-Hexadecenoic Acid methyl ester | 10 mg |
| CAY-10006864-M050 | cis-7-Hexadecenoic Acid methyl ester | 50 mg |
| CAY-10006864-M100 | cis-7-Hexadecenoic Acid methyl ester | 100 mg |
| CAY-10006865-M050 | Docosahexaenoic Acid methyl ester | 50 mg |
| CAY-10006865-M100 | Docosahexaenoic Acid methyl ester | 100 mg |
| CAY-10006865-M500 | Docosahexaenoic Acid methyl ester | 500 mg |
| CAY-10006865-G001 | Docosahexaenoic Acid methyl ester | 1 g |
| CAY-10006866-M005 | cis-4,10,13,16-Docosatetraenoic Acid methyl ester | 5 mg |
| CAY-10006866-M010 | cis-4,10,13,16-Docosatetraenoic Acid methyl ester | 10 mg |
| CAY-10006866-M050 | cis-4,10,13,16-Docosatetraenoic Acid methyl ester | 50 mg |
| CAY-10006866-M100 | cis-4,10,13,16-Docosatetraenoic Acid methyl ester | 100 mg |
| CAY-10006874-M005 | Ethyl tricosanoate | 5 mg |
| CAY-10006874-M010 | Ethyl tricosanoate | 10 mg |
| CAY-10006874-M050 | Ethyl tricosanoate | 50 mg |
| CAY-10006874-M100 | Ethyl tricosanoate | 100 mg |
| CAY-10006876-G001 | Diethylstilbestrol | 1 g |
| CAY-10006876-G005 | Diethylstilbestrol | 5 g |
| CAY-10006876-G010 | Diethylstilbestrol | 10 g |
| CAY-10006876-G025 | Diethylstilbestrol | 25 g |
| CAY-10006878-C010 | (+/-)5-8,12-iso-iPF2.alpha.VI-d11 | 10 ug |
| CAY-10006878-C025 | (+/-)5-8,12-iso-iPF2.alpha.VI-d11 | 25 ug |
| CAY-10006878-C050 | (+/-)5-8,12-iso-iPF2.alpha.VI-d11 | 50 ug |
| CAY-10006878-C100 | (+/-)5-8,12-iso-iPF2.alpha.VI-d11 | 100 ug |
| CAY-10006909-KI01 | ChREBP Transcription Factor Assay Kit | 96 wells |
| CAY-10006914-KI01 | PPARdelta Transcription Factor Assay Kit | 96 wells |
| CAY-10006915-KI01 | PPARalpha Transcription Factor Assay Kit | 96 wells |
| CAY-10006943-KI01 | Vitellogenin (fathead minnow) EIA Kit (pre-coated) | 96 wells |
| CAY-10006943-KI04 | Vitellogenin (fathead minnow) EIA Kit (pre-coated) | 480 wells |
| CAY-10006966-C100 | Nitrotyrosine Monoclonal Antibody - Biotinylated | 100 ug |
| CAY-10006968-M001 | NO-Hydrocortisone | 1 mg |
| CAY-10006968-M005 | NO-Hydrocortisone | 5 mg |
| CAY-10006968-M010 | NO-Hydrocortisone | 10 mg |
| CAY-10006968-M050 | NO-Hydrocortisone | 50 mg |
| CAY-10006976-M050 | Thiocarlide | 50 mg |
| CAY-10006976-M100 | Thiocarlide | 100 mg |
| CAY-10006976-M500 | Thiocarlide | 500 mg |
| CAY-10006976-G001 | Thiocarlide | 1 g |
| CAY-10006984-C200 | LPA1 Blocking Peptide | 200 ug |
| CAY-10006987-C050 | Prostaglandin E2-biotinimide | 50 ug |
| CAY-10006987-C100 | Prostaglandin E2-biotinimide | 100 ug |
| CAY-10006987-C500 | Prostaglandin E2-biotinimide | 500 ug |
| CAY-10006987-M001 | Prostaglandin E2-biotinimide | 1 mg |
| CAY-10006988-C050 | Prostaglandin F2.alpha.-biotinimide | 50 ug |
| CAY-10006988-C100 | Prostaglandin F2.alpha.-biotinimide | 100 ug |
| CAY-10006988-C500 | Prostaglandin F2.alpha.-biotinimide | 500 ug |
| CAY-10006988-M001 | Prostaglandin F2.alpha.-biotinimide | 1 mg |
| CAY-10006995-M500 | Piloty's Acid | 500 mg |
| CAY-10006995-G001 | Piloty's Acid | 1 g |
| CAY-10006995-G005 | Piloty's Acid | 5 g |
| CAY-10006995-G010 | Piloty's Acid | 10 g |
| CAY-10006998-C025 | 14,15-Dihydroxy-Eicosa-5,8,11,17-Tetraenoic Acid | 25 ug |
| CAY-10006998-C050 | 14,15-Dihydroxy-Eicosa-5,8,11,17-Tetraenoic Acid | 50 ug |
| CAY-10006998-C100 | 14,15-Dihydroxy-Eicosa-5,8,11,17-Tetraenoic Acid | 100 ug |
| CAY-10006998-C250 | 14,15-Dihydroxy-Eicosa-5,8,11,17-Tetraenoic Acid | 250 ug |
| CAY-10006999-C025 | 17,18-Dihydroxy-Eicosa-5,8,11,14-Tetraenoic Acid | 25 ug |
| CAY-10006999-C050 | 17,18-Dihydroxy-Eicosa-5,8,11,14-Tetraenoic Acid | 50 ug |
| CAY-10006999-C100 | 17,18-Dihydroxy-Eicosa-5,8,11,14-Tetraenoic Acid | 100 ug |
| CAY-10006999-C250 | 17,18-Dihydroxy-Eicosa-5,8,11,14-Tetraenoic Acid | 250 ug |
| CAY-10007001-C050 | (±)19,20-DiHDPA | 50 ug |
| CAY-10007001-C100 | (±)19,20-DiHDPA | 100 ug |
| CAY-10007001-C500 | (±)19,20-DiHDPA | 500 ug |
| CAY-10007001-M001 | (±)19,20-DiHDPA | 1 mg |
| CAY-10007002-1 | CRTH2-DP2 (C-Term) Polyclonal Antibody | 1 ea |
| CAY-10007003-1 | CRTH2/DP2 Receptor (C-Term) Blocking Peptide | 1 ea |
| CAY-10007014-M001 | N-Ac-DEVD-N'-MC-R110 | 1 mg |
| CAY-10007014-M005 | N-Ac-DEVD-N'-MC-R110 | 5 mg |
| CAY-10007014-M010 | N-Ac-DEVD-N'-MC-R110 | 10 mg |
| CAY-10007014-M025 | N-Ac-DEVD-N'-MC-R110 | 25 mg |
| CAY-10007048-R100 | Vitellogenin (bird) Monoclonal Antibody (ND-3C3) | 100 ul |
| CAY-10007048-R500 | Vitellogenin (bird) Monoclonal Antibody (ND-3C3) | 500 ul |
| CAY-10007049-R100 | Vitellogenin (bird) Monoclonal Antibody (ND-3G6) | 100 ul |
| CAY-10007049-R500 | Vitellogenin (bird) Monoclonal Antibody (ND-3G6) | 500 ul |
| CAY-10007073-1 | PTEN Blocking Peptide | 1 ea |
| CAY-10007072-M005 | 1-Palmitoyl-2-linoleoyl PE | 5 mg |
| CAY-10007072-M010 | 1-Palmitoyl-2-linoleoyl PE | 10 mg |
| CAY-10007072-M050 | 1-Palmitoyl-2-linoleoyl PE | 50 mg |
| CAY-10007072-M100 | 1-Palmitoyl-2-linoleoyl PE | 100 mg |
| CAY-10007075-M100 | 4-(1-Piperazinyl)-1H-Indole (dihydrochloride) | 100 mg |
| CAY-10007075-M250 | 4-(1-Piperazinyl)-1H-Indole (dihydrochloride) | 250 mg |
| CAY-10007075-M500 | 4-(1-Piperazinyl)-1H-Indole (dihydrochloride) | 500 mg |
| CAY-10007075-G001 | 4-(1-Piperazinyl)-1H-Indole (dihydrochloride) | 1 g |
| CAY-10007076-M100 | CAY10491 | 100 mg |
| CAY-10007076-M500 | CAY10491 | 500 mg |
| CAY-10007076-G001 | CAY10491 | 1 g |
| CAY-10007076-G005 | CAY10491 | 5 g |
| CAY-10007077-M100 | CAY10492 | 100 mg |
| CAY-10007077-M500 | CAY10492 | 500 mg |
| CAY-10007077-G001 | CAY10492 | 1 g |
| CAY-10007077-G005 | CAY10492 | 5 g |
| CAY-10007078-M100 | CAY10493 | 100 mg |
| CAY-10007078-M500 | CAY10493 | 500 mg |
| CAY-10007078-G001 | CAY10493 | 1 g |
| CAY-10007078-G005 | CAY10493 | 5 g |
| CAY-10007079-M050 | 5-Bromoisoquinoline | 50 mg |
| CAY-10007079-M100 | 5-Bromoisoquinoline | 100 mg |
| CAY-10007079-M500 | 5-Bromoisoquinoline | 500 mg |
| CAY-10007079-G001 | 5-Bromoisoquinoline | 1 g |
| CAY-10007080-M050 | 6-Bromoisoquinoline | 50 mg |
| CAY-10007080-M100 | 6-Bromoisoquinoline | 100 mg |
| CAY-10007080-M500 | 6-Bromoisoquinoline | 500 mg |
| CAY-10007080-G001 | 6-Bromoisoquinoline | 1 g |
| CAY-10007081-M050 | 7-Bromoisoquinoline | 50 mg |
| CAY-10007081-M100 | 7-Bromoisoquinoline | 100 mg |
| CAY-10007081-M500 | 7-Bromoisoquinoline | 500 mg |
| CAY-10007081-G001 | 7-Bromoisoquinoline | 1 g |
| CAY-10007082-M050 | 8-Bromoisoquinoline | 50 mg |
| CAY-10007082-M100 | 8-Bromoisoquinoline | 100 mg |
| CAY-10007082-M500 | 8-Bromoisoquinoline | 500 mg |
| CAY-10007082-G001 | 8-Bromoisoquinoline | 1 g |
| CAY-10007083-M050 | 5,6,7,8-Tetrahydro-2-Quinolone | 50 mg |
| CAY-10007083-M100 | 5,6,7,8-Tetrahydro-2-Quinolone | 100 mg |
| CAY-10007083-M500 | 5,6,7,8-Tetrahydro-2-Quinolone | 500 mg |
| CAY-10007083-G001 | 5,6,7,8-Tetrahydro-2-Quinolone | 1 g |
| CAY-10007084-M500 | 4-Cyanoindole | 500 mg |
| CAY-10007084-G001 | 4-Cyanoindole | 1 g |
| CAY-10007084-G005 | 4-Cyanoindole | 5 g |
| CAY-10007084-G010 | 4-Cyanoindole | 10 g |
| CAY-10007085-M100 | 4-Aminomethylindole | 100 mg |
| CAY-10007085-M500 | 4-Aminomethylindole | 500 mg |
| CAY-10007085-G001 | 4-Aminomethylindole | 1 g |
| CAY-10007085-G005 | 4-Aminomethylindole | 5 g |
| CAY-10007086-M500 | 4-Formylindole | 500 mg |
| CAY-10007086-G001 | 4-Formylindole | 1 g |
| CAY-10007086-G005 | 4-Formylindole | 5 g |
| CAY-10007086-G010 | 4-Formylindole | 10 g |
| CAY-10007087-M100 | (1H-Indol-4-yl)-carbamic Acid tert-Butyl-ester | 100 mg |
| CAY-10007087-M500 | (1H-Indol-4-yl)-carbamic Acid tert-Butyl-ester | 500 mg |
| CAY-10007087-G001 | (1H-Indol-4-yl)-carbamic Acid tert-Butyl-ester | 1 g |
| CAY-10007087-G005 | (1H-Indol-4-yl)-carbamic Acid tert-Butyl-ester | 5 g |
| CAY-10007089-M500 | N-(Diphenylmethylene)glycine benzyl ester | 500 mg |
| CAY-10007089-G001 | N-(Diphenylmethylene)glycine benzyl ester | 1 g |
| CAY-10007089-G005 | N-(Diphenylmethylene)glycine benzyl ester | 5 g |
| CAY-10007089-G010 | N-(Diphenylmethylene)glycine benzyl ester | 10 g |
| CAY-10007091-M100 | N,N-Dimethyl-L-Valine | 100 mg |
| CAY-10007091-M500 | N,N-Dimethyl-L-Valine | 500 mg |
| CAY-10007091-G001 | N,N-Dimethyl-L-Valine | 1 g |
| CAY-10007091-G005 | N,N-Dimethyl-L-Valine | 5 g |
| CAY-10007092-M500 | N-Pivaloylaniline | 500 mg |
| CAY-10007092-G001 | N-Pivaloylaniline | 1 g |
| CAY-10007092-G005 | N-Pivaloylaniline | 5 g |
| CAY-10007092-G010 | N-Pivaloylaniline | 10 g |
| CAY-10007093-G005 | 2-Aminopyrazine | 5 g |
| CAY-10007093-G010 | 2-Aminopyrazine | 10 g |
| CAY-10007093-G025 | 2-Aminopyrazine | 25 g |
| CAY-10007093-G050 | 2-Aminopyrazine | 50 g |
| CAY-10007094-M100 | 7-Chlorothieno[2,3-c]pyridine | 100 mg |
| CAY-10007094-M500 | 7-Chlorothieno[2,3-c]pyridine | 500 mg |
| CAY-10007094-G001 | 7-Chlorothieno[2,3-c]pyridine | 1 g |
| CAY-10007094-G005 | 7-Chlorothieno[2,3-c]pyridine | 5 g |
| CAY-10007102-G001 | 3-Thiopheneacrylic Acid methyl ester | 1 g |
| CAY-10007102-G005 | 3-Thiopheneacrylic Acid methyl ester | 5 g |
| CAY-10007102-G010 | 3-Thiopheneacrylic Acid methyl ester | 10 g |
| CAY-10007102-G025 | 3-Thiopheneacrylic Acid methyl ester | 25 g |
| CAY-10007103-G001 | 3-Thiopheneacrylic Acid | 1 g |
| CAY-10007103-G005 | 3-Thiopheneacrylic Acid | 5 g |
| CAY-10007103-G010 | 3-Thiopheneacrylic Acid | 10 g |
| CAY-10007103-G025 | 3-Thiopheneacrylic Acid | 25 g |
| CAY-10007106-M050 | 2-Aminomethylpyrimidine . hydrochloride | 50 mg |
| CAY-10007106-M100 | 2-Aminomethylpyrimidine . hydrochloride | 100 mg |
| CAY-10007106-M500 | 2-Aminomethylpyrimidine . hydrochloride | 500 mg |
| CAY-10007106-G001 | 2-Aminomethylpyrimidine . hydrochloride | 1 g |
| CAY-10007107-M050 | 3-Pyrimidin-4-yl-propionic Acid | 50 mg |
| CAY-10007107-M100 | 3-Pyrimidin-4-yl-propionic Acid | 100 mg |
| CAY-10007107-M500 | 3-Pyrimidin-4-yl-propionic Acid | 500 mg |
| CAY-10007107-G001 | 3-Pyrimidin-4-yl-propionic Acid | 1 g |
| CAY-10007108-M100 | 2-Pyrimidin-2-yl-propionic Acid | 100 mg |
| CAY-10007108-M500 | 2-Pyrimidin-2-yl-propionic Acid | 500 mg |
| CAY-10007108-G001 | 2-Pyrimidin-2-yl-propionic Acid | 1 g |
| CAY-10007108-G005 | 2-Pyrimidin-2-yl-propionic Acid | 5 g |
| CAY-10007109-M050 | 3-Pyrimidin-2-yl-Propionic Acid | 50 mg |
| CAY-10007109-M100 | 3-Pyrimidin-2-yl-Propionic Acid | 100 mg |
| CAY-10007109-M500 | 3-Pyrimidin-2-yl-Propionic Acid | 500 mg |
| CAY-10007109-G001 | 3-Pyrimidin-2-yl-Propionic Acid | 1 g |
| CAY-10007110-M100 | 3-Pyrimidin-2-yl-2-pyrimidin-2-yl-methylpropionic Acid | 100 mg |
| CAY-10007110-M500 | 3-Pyrimidin-2-yl-2-pyrimidin-2-yl-methylpropionic Acid | 500 mg |
| CAY-10007110-G001 | 3-Pyrimidin-2-yl-2-pyrimidin-2-yl-methylpropionic Acid | 1 g |
| CAY-10007110-G005 | 3-Pyrimidin-2-yl-2-pyrimidin-2-yl-methylpropionic Acid | 5 g |
| CAY-10007111-M050 | Pyrimidin-4-yl-methanol | 50 mg |
| CAY-10007111-M100 | Pyrimidin-4-yl-methanol | 100 mg |
| CAY-10007111-M500 | Pyrimidin-4-yl-methanol | 500 mg |
| CAY-10007111-G001 | Pyrimidin-4-yl-methanol | 1 g |
| CAY-10007112-M050 | 2-(Hydroxymethyl)-Pyrimidine | 50 mg |
| CAY-10007112-M100 | 2-(Hydroxymethyl)-Pyrimidine | 100 mg |
| CAY-10007112-M500 | 2-(Hydroxymethyl)-Pyrimidine | 500 mg |
| CAY-10007112-G001 | 2-(Hydroxymethyl)-Pyrimidine | 1 g |
| CAY-10007113-M100 | Pyrimidine-4-carboxylic Acid (sodium salt) | 100 mg |
| CAY-10007113-M500 | Pyrimidine-4-carboxylic Acid (sodium salt) | 500 mg |
| CAY-10007113-G001 | Pyrimidine-4-carboxylic Acid (sodium salt) | 1 g |
| CAY-10007113-G005 | Pyrimidine-4-carboxylic Acid (sodium salt) | 5 g |
| CAY-10007114-M100 | Methyl-4-pyrimidinecarboxylate | 100 mg |
| CAY-10007114-M500 | Methyl-4-pyrimidinecarboxylate | 500 mg |
| CAY-10007114-G001 | Methyl-4-pyrimidinecarboxylate | 1 g |
| CAY-10007114-G005 | Methyl-4-pyrimidinecarboxylate | 5 g |
| CAY-10007115-M050 | Pyrimidin-4-yl-acetic Acid | 50 mg |
| CAY-10007115-M100 | Pyrimidin-4-yl-acetic Acid | 100 mg |
| CAY-10007115-M500 | Pyrimidin-4-yl-acetic Acid | 500 mg |
| CAY-10007115-G001 | Pyrimidin-4-yl-acetic Acid | 1 g |
| CAY-10007116-M100 | 2-Pyrimidine Acetic Acid | 100 mg |
| CAY-10007116-M500 | 2-Pyrimidine Acetic Acid | 500 mg |
| CAY-10007116-G001 | 2-Pyrimidine Acetic Acid | 1 g |
| CAY-10007116-G005 | 2-Pyrimidine Acetic Acid | 5 g |
| CAY-10007117-M050 | 2-Methyl-3-pyrimidin-4-yl-propionic Acid | 50 mg |
| CAY-10007117-M100 | 2-Methyl-3-pyrimidin-4-yl-propionic Acid | 100 mg |
| CAY-10007117-M500 | 2-Methyl-3-pyrimidin-4-yl-propionic Acid | 500 mg |
| CAY-10007117-G001 | 2-Methyl-3-pyrimidin-4-yl-propionic Acid | 1 g |
| CAY-10007118-M050 | 2-Methyl-3-pyrimidin-2-yl-propionic Acid | 50 mg |
| CAY-10007118-M100 | 2-Methyl-3-pyrimidin-2-yl-propionic Acid | 100 mg |
| CAY-10007118-M500 | 2-Methyl-3-pyrimidin-2-yl-propionic Acid | 500 mg |
| CAY-10007118-G001 | 2-Methyl-3-pyrimidin-2-yl-propionic Acid | 1 g |
| CAY-10007119-M050 | Methyl-2-Pyrimidine Carboxylate | 50 mg |
| CAY-10007119-M100 | Methyl-2-Pyrimidine Carboxylate | 100 mg |
| CAY-10007119-M500 | Methyl-2-Pyrimidine Carboxylate | 500 mg |
| CAY-10007119-G001 | Methyl-2-Pyrimidine Carboxylate | 1 g |
| CAY-10007120-M100 | 4-Pyrimidinecarboxaldehyde-dimethylacetal | 100 mg |
| CAY-10007120-M500 | 4-Pyrimidinecarboxaldehyde-dimethylacetal | 500 mg |
| CAY-10007120-G001 | 4-Pyrimidinecarboxaldehyde-dimethylacetal | 1 g |
| CAY-10007120-G005 | 4-Pyrimidinecarboxaldehyde-dimethylacetal | 5 g |
| CAY-10007121-M100 | 2-Cyano-pyrimidine | 100 mg |
| CAY-10007121-M500 | 2-Cyano-pyrimidine | 500 mg |
| CAY-10007121-G001 | 2-Cyano-pyrimidine | 1 g |
| CAY-10007121-G005 | 2-Cyano-pyrimidine | 5 g |
| CAY-10007122-M050 | 2-(Chloromethyl)-pyrimidine | 50 mg |
| CAY-10007122-M100 | 2-(Chloromethyl)-pyrimidine | 100 mg |
| CAY-10007122-M500 | 2-(Chloromethyl)-pyrimidine | 500 mg |
| CAY-10007122-G001 | 2-(Chloromethyl)-pyrimidine | 1 g |
| CAY-10007123-M100 | 2-Carboxy-pyrimidine | 100 mg |
| CAY-10007123-M500 | 2-Carboxy-pyrimidine | 500 mg |
| CAY-10007123-G001 | 2-Carboxy-pyrimidine | 1 g |
| CAY-10007123-G005 | 2-Carboxy-pyrimidine | 5 g |
| CAY-10007124-M050 | 4-Pyrimidinemethanamine | 50 mg |
| CAY-10007124-M100 | 4-Pyrimidinemethanamine | 100 mg |
| CAY-10007124-M500 | 4-Pyrimidinemethanamine | 500 mg |
| CAY-10007124-G001 | 4-Pyrimidinemethanamine | 1 g |
| CAY-10007125-M050 | 8-Isoquinolinemethanamine . dihydrochloride | 50 mg |
| CAY-10007125-M100 | 8-Isoquinolinemethanamine . dihydrochloride | 100 mg |
| CAY-10007125-M500 | 8-Isoquinolinemethanamine . dihydrochloride | 500 mg |
| CAY-10007125-G001 | 8-Isoquinolinemethanamine . dihydrochloride | 1 g |
| CAY-10007126-M100 | CAY10494 | 100 mg |
| CAY-10007126-M500 | CAY10494 | 500 mg |
| CAY-10007126-G001 | CAY10494 | 1 g |
| CAY-10007126-G005 | CAY10494 | 5 g |
| CAY-10007127-G005 | 5-Chlororesorcinol dimethyl ether | 5 g |
| CAY-10007127-G010 | 5-Chlororesorcinol dimethyl ether | 10 g |
| CAY-10007127-G025 | 5-Chlororesorcinol dimethyl ether | 25 g |
| CAY-10007127-G050 | 5-Chlororesorcinol dimethyl ether | 50 g |
| CAY-10007128-G005 | R-(-)-Mandelic acid | 5 g |
| CAY-10007128-G010 | R-(-)-Mandelic acid | 10 g |
| CAY-10007128-G025 | R-(-)-Mandelic acid | 25 g |
| CAY-10007128-G050 | R-(-)-Mandelic acid | 50 g |
| CAY-10007129-G001 | tert-Butyl p-(Bromomethyl) benzoate | 1 g |
| CAY-10007129-G005 | tert-Butyl p-(Bromomethyl) benzoate | 5 g |
| CAY-10007129-G010 | tert-Butyl p-(Bromomethyl) benzoate | 10 g |
| CAY-10007129-G025 | tert-Butyl p-(Bromomethyl) benzoate | 25 g |
| CAY-10007130-G001 | tert-Butyl-p-toluate | 1 g |
| CAY-10007130-G005 | tert-Butyl-p-toluate | 5 g |
| CAY-10007130-G010 | tert-Butyl-p-toluate | 10 g |
| CAY-10007130-G050 | tert-Butyl-p-toluate | 50 g |
| CAY-10007131-M500 | 5,6,7,8-Tetrahydro-2-naphthoic Acid | 500 mg |
| CAY-10007131-G001 | 5,6,7,8-Tetrahydro-2-naphthoic Acid | 1 g |
| CAY-10007131-G005 | 5,6,7,8-Tetrahydro-2-naphthoic Acid | 5 g |
| CAY-10007131-G010 | 5,6,7,8-Tetrahydro-2-naphthoic Acid | 10 g |
| CAY-10007132-G001 | (R)-(-)-2-Phenylglycinol | 1 g |
| CAY-10007132-G005 | (R)-(-)-2-Phenylglycinol | 5 g |
| CAY-10007132-G010 | (R)-(-)-2-Phenylglycinol | 10 g |
| CAY-10007132-G025 | (R)-(-)-2-Phenylglycinol | 25 g |
| CAY-10007133-M001 | CMPF | 1 mg |
| CAY-10007133-M005 | CMPF | 5 mg |
| CAY-10007133-M010 | CMPF | 10 mg |
| CAY-10007133-M050 | CMPF | 50 mg |
| CAY-10007134-M050 | 5-Bromotetralone | 50 mg |
| CAY-10007134-M100 | 5-Bromotetralone | 100 mg |
| CAY-10007134-M250 | 5-Bromotetralone | 250 mg |
| CAY-10007134-M500 | 5-Bromotetralone | 500 mg |
| CAY-10007135-M050 | 7-Bromotetralone | 50 mg |
| CAY-10007135-M100 | 7-Bromotetralone | 100 mg |
| CAY-10007135-M250 | 7-Bromotetralone | 250 mg |
| CAY-10007135-M500 | 7-Bromotetralone | 500 mg |
| CAY-10007136-M050 | 7-Piperazin-1-yl-thieno[2,3-c]-pyridine . hydrochloride | 50 mg |
| CAY-10007136-M100 | 7-Piperazin-1-yl-thieno[2,3-c]-pyridine . hydrochloride | 100 mg |
| CAY-10007136-M250 | 7-Piperazin-1-yl-thieno[2,3-c]-pyridine . hydrochloride | 250 mg |
| CAY-10007136-M500 | 7-Piperazin-1-yl-thieno[2,3-c]-pyridine . hydrochloride | 500 mg |
| CAY-10007138-G001 | 2-Methyl-1,3-cyclohexanedione | 1 g |
| CAY-10007138-G005 | 2-Methyl-1,3-cyclohexanedione | 5 g |
| CAY-10007138-G010 | 2-Methyl-1,3-cyclohexanedione | 10 g |
| CAY-10007138-G050 | 2-Methyl-1,3-cyclohexanedione | 50 g |
| CAY-10007139-1 | PI-9 Monoclonal Antibody (7D8) | 1 ea |
| CAY-10007143-KI01 | Vitellogenin (alligator) Monoclonal Antibody (ND-1E8) | 100 ul |
| CAY-10007143-KI04 | Vitellogenin (alligator) Monoclonal Antibody (ND-1E8) | 480 wells |
| CAY-10007145-G001 | (R)-Benzyl mandelate | 1 g |
| CAY-10007145-G005 | (R)-Benzyl mandelate | 5 g |
| CAY-10007145-G010 | (R)-Benzyl mandelate | 10 g |
| CAY-10007145-G050 | (R)-Benzyl mandelate | 50 g |
| CAY-10007146-M050 | 8-Piperazin-1-yl-isoquinoline . hydrochloride | 50 mg |
| CAY-10007146-M100 | 8-Piperazin-1-yl-isoquinoline . hydrochloride | 100 mg |
| CAY-10007146-M500 | 8-Piperazin-1-yl-isoquinoline . hydrochloride | 500 mg |
| CAY-10007146-G001 | 8-Piperazin-1-yl-isoquinoline . hydrochloride | 1 g |
| CAY-10007147-M050 | 7-Piperazin-1-yl-isoquinoline (hydrochloride) | 50 mg |
| CAY-10007147-M100 | 7-Piperazin-1-yl-isoquinoline (hydrochloride) | 100 mg |
| CAY-10007147-M500 | 7-Piperazin-1-yl-isoquinoline (hydrochloride) | 500 mg |
| CAY-10007147-G001 | 7-Piperazin-1-yl-isoquinoline (hydrochloride) | 1 g |
| CAY-10007148-M050 | 6-Piperazin-1-yl-isoquinoline . hydrochloride | 50 mg |
| CAY-10007148-M100 | 6-Piperazin-1-yl-isoquinoline . hydrochloride | 100 mg |
| CAY-10007148-M500 | 6-Piperazin-1-yl-isoquinoline . hydrochloride | 500 mg |
| CAY-10007148-G001 | 6-Piperazin-1-yl-isoquinoline . hydrochloride | 1 g |
| CAY-10007149-M100 | (R)-N-Acetyl-2-nitro-2-phenylglycinol-O-acetate | 100 mg |
| CAY-10007149-M500 | (R)-N-Acetyl-2-nitro-2-phenylglycinol-O-acetate | 500 mg |
| CAY-10007149-G001 | (R)-N-Acetyl-2-nitro-2-phenylglycinol-O-acetate | 1 g |
| CAY-10007149-G005 | (R)-N-Acetyl-2-nitro-2-phenylglycinol-O-acetate | 5 g |
| CAY-10007150-M100 | (R)-N-Acetyl-4-nitro-2-phenylglycinol-O-acetate | 100 mg |
| CAY-10007150-M500 | (R)-N-Acetyl-4-nitro-2-phenylglycinol-O-acetate | 500 mg |
| CAY-10007150-G001 | (R)-N-Acetyl-4-nitro-2-phenylglycinol-O-acetate | 1 g |
| CAY-10007150-G005 | (R)-N-Acetyl-4-nitro-2-phenylglycinol-O-acetate | 5 g |
| CAY-10007164-C025 | Leukotriene C4 methyl ester | 25 ug |
| CAY-10007164-C050 | Leukotriene C4 methyl ester | 50 ug |
| CAY-10007164-C100 | Leukotriene C4 methyl ester | 100 ug |
| CAY-10007164-C500 | Leukotriene C4 methyl ester | 500 ug |
| CAY-10007165-C025 | Leukotriene D4 methyl ester | 25 ug |
| CAY-10007165-C050 | Leukotriene D4 methyl ester | 50 ug |
| CAY-10007165-C100 | Leukotriene D4 methyl ester | 100 ug |
| CAY-10007165-C500 | Leukotriene D4 methyl ester | 500 ug |
| CAY-10007166-C025 | Leukotriene E4 methyl ester | 25 ug |
| CAY-10007166-C050 | Leukotriene E4 methyl ester | 50 ug |
| CAY-10007166-C100 | Leukotriene E4 methyl ester | 100 ug |
| CAY-10007166-C500 | Leukotriene E4 methyl ester | 500 ug |
| CAY-10007171-M005 | Cetaben | 5 mg |
| CAY-10007171-M010 | Cetaben | 10 mg |
| CAY-10007171-M050 | Cetaben | 50 mg |
| CAY-10007171-M100 | Cetaben | 100 mg |
| CAY-10007185-1 | PCSK9 Polyclonal Antibody | 1 ea |
| CAY-10007186-1 | PCSK9 Blocking Peptide | 1 ea |
| CAY-10007188-C050 | Microcystin-LR | 50 ug |
| CAY-10007188-C100 | Microcystin-LR | 100 ug |
| CAY-10007188-C500 | Microcystin-LR | 500 ug |
| CAY-10007188-M001 | Microcystin-LR | 1 mg |
| CAY-10007190-C050 | Nodularin | 50 ug |
| CAY-10007190-C100 | Nodularin | 100 ug |
| CAY-10007190-C500 | Nodularin | 500 ug |
| CAY-10007190-M001 | Nodularin | 1 mg |
| CAY-10007191-1 | PH Domain Leucine-rich Repeat Protein Phosphotase Polyclonal Antibody | 1 ea |
| CAY-10007192-1 | PH Domain Leucine-rich Repeat Protein Phosphatase Blocking Peptide | 1 ea |
| CAY-10007193-1 | Lysophospholipase D Blocking Peptide | 1 ea |
